MENU
BOUT
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

BOUT stock forecast, quote, news & analysis

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index")... Show more

Category: #Mid-Cap Growth
BOUT
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for BOUT with price predictions
Oct 01, 2026

BOUT in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 15, 2026

BOUT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 34 cases where BOUT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BOUT's RSI Oscillator exited the oversold zone, 17 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 55 cases where BOUT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

The Moving Average Convergence Divergence (MACD) for BOUT just turned positive on September 24, 2026. Looking at past instances where BOUT's MACD turned positive, the stock continued to rise in 41 of 49 cases over the following month. The odds of a continued upward trend are 84%.

Following a +1.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where BOUT advanced for three days, in 287 of 346 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BOUT as a result. In 77 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BOUT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.

The Aroon Indicator for BOUT entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Bank of America Corp (NYSE:BAC), Wells Fargo & Co (NYSE:WFC), Newmont Corp (NYSE:NEM), WisdomTree (NYSE:WT).

Industry description

The investment seeks to track, before fees and expenses, the performance of the IBD® Breakout Stocks Index (the "index"). The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock’s recent “resistance level,” with consideration for various market conditions. The fund is non-diversified.

Market Cap

The average market capitalization across the CapForce IBD Breakout Opportunities ETF (BOUT) ETF is 103.93B. The market cap for tickers in the group ranges from 908.18M to 387.89B. BAC holds the highest valuation in this group at 387.89B. The lowest valued company is DJCO at 908.18M.

High and low price notable news

The average weekly price growth across all stocks in the CapForce IBD Breakout Opportunities ETF (BOUT) ETF was 14%. For the same ETF, the average monthly price growth was 30%, and the average quarterly price growth was 187%. ECO experienced the highest price growth at 10%, while NESR experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the CapForce IBD Breakout Opportunities ETF (BOUT) ETF was 9%. For the same stocks of the ETF, the average monthly volume growth was 9% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 60
Price Growth Rating: 55
SMR Rating: 52
Profit Risk Rating: 49
Seasonality Score: 35 (-100 ... +100)
View a ticker or compare two or three
BOUT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MidCapGrowth

Category
Mid-Cap Growth
Address
Academy Funds Trust123 South Broad Street, Suite 1630Philadelphia
Phone
(215) 979-3750
Web
www.innovatorfunds.com
BOUT in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 15, 2026